Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to …
Global Burden of Disease Cancer Collaboration - JAMA oncology, 2019 - research.ed.ac.uk
Objective: To describe cancer burden for 29 cancer groups in 195 countries from 1990
through 2017 to provide data needed for cancer control planning. Evidence Review: We …
through 2017 to provide data needed for cancer control planning. Evidence Review: We …
Emerging trends in the novel drug delivery approaches for the treatment of lung cancer
Cancer is one of the major diseases that cause a high number of deaths globally. Of the
major types of cancers, lung cancer is known to be the most chronic form of cancer in the …
major types of cancers, lung cancer is known to be the most chronic form of cancer in the …
Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors
B Waissengrin, A Agbarya, E Safadi, H Padova… - The Lancet …, 2021 - thelancet.com
Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated
with immune checkpoint inhibitors - The Lancet Oncology Skip to Main Content …
with immune checkpoint inhibitors - The Lancet Oncology Skip to Main Content …
Burden of liver diseases in the world
Liver disease accounts for approximately 2 million deaths per year worldwide, 1 million due
to complications of cirrhosis and 1 million due to viral hepatitis and hepatocellular …
to complications of cirrhosis and 1 million due to viral hepatitis and hepatocellular …
Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies
The link between depression and anxiety status and cancer outcomes has been well-
documented but remains unclear. We comprehensively quantified the association between …
documented but remains unclear. We comprehensively quantified the association between …
[HTML][HTML] Evolution of cancer pharmacological treatments at the turn of the third millennium
The medical history of cancer began millennia ago. Historical findings of patients with
cancer date back to ancient Egyptian and Greek civilizations, where this disease was …
cancer date back to ancient Egyptian and Greek civilizations, where this disease was …
[HTML][HTML] METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST
X Yang, S Zhang, C He, P Xue, L Zhang, Z He, L Zang… - Molecular cancer, 2020 - Springer
Abstract Background N6-methyladenosine (m6A) is the most prevalent RNA epigenetic
regulation in eukaryotic cells. However, understanding of m6A in colorectal cancer (CRC) is …
regulation in eukaryotic cells. However, understanding of m6A in colorectal cancer (CRC) is …
[HTML][HTML] Cost-effectiveness of artificial intelligence for screening colonoscopy: a modelling study
Background Artificial intelligence (AI) tools increase detection of precancerous polyps during
colonoscopy and might contribute to long-term colorectal cancer prevention. The aim of the …
colonoscopy and might contribute to long-term colorectal cancer prevention. The aim of the …
[HTML][HTML] Measuring population ageing: an analysis of the Global Burden of Disease Study 2017
Background Traditional metrics for population health ageing tend not to differentiate
between extending life expectancy and adding healthy years. A population ageing metric …
between extending life expectancy and adding healthy years. A population ageing metric …
[HTML][HTML] Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label …
Background Targeting the programmed cell death protein 1 (PD-1)/programmed cell death
ligand 1 (PD-L1) axis has demonstrated clinical benefit in recurrent/metastatic head and …
ligand 1 (PD-L1) axis has demonstrated clinical benefit in recurrent/metastatic head and …